John Tse is a nationally recognized pharmacy executive, healthcare innovator, and the current Vice President of Commercialization at Light AI, a Canadian medical technology company specializing in AI-powered diagnostics for respiratory infections. With over 25 years of leadership experience in pharmacy operations, public health innovation, and digital health strategy, John brings deep expertise in bridging clinical needs with scalable, technology-driven solutions.

John’s extensive background includes executive leadership at London Drugs, where he was responsible for expanding healthcare services across community pharmacy locations, championing innovations in patient care, and operationalizing new clinical services. His practical experience in frontline care delivery, retail health operations, and pharmacist-led health programs uniquely positions him to lead the commercialization of Light AI’s diagnostic platform across pharmacies, clinics, travel health, and long-term care settings.

In addition to his work with Light AI, John is the Founder of 36Eight Technologies, the company behind C/R/I/S (Cannabis Recognition and Intelligent Support), an AI-driven clinical platform designed to help healthcare professionals navigate cannabinoid therapy. The tool supports personalized product selection, drug–cannabis interaction screening, dosing guidance, and titration monitoring—reflecting John’s commitment to integrating emerging therapeutics into mainstream care through safe, evidence-based frameworks.

John has received multiple national awards for his contributions to pharmacy and healthcare innovation, including the Lifetime Achievement Award from the BC Pharmacy Association and the Len Marks Pharmacy Advancement Award from the Neighbourhood Pharmacy Association of Canada. At Health Summit 2025, John will contribute to the AI panel with insights into how artificial intelligence can accelerate access to care, enhance diagnostic precision, and support responsible innovation across the healthcare ecosystem.